长期使用氧化导致心肌病和导电异常:病例报告
Timothy Ryan1, Laura Luttrell2, Amit Shah1
1Advanced Heart Failure and Cardiac Transplant Service, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, WA 6150, Australia.
European heart journal. Case reports
|September 5, 2025
概括
诊断不分化的左心室缩 (LVH) 可能具有挑战性. 这一病例突显了氧化诱导的心肌病 (HCQ-CM) 是长期使用氧化治疗的患者心力衰竭的罕见但可逆的原因.
科学领域:
- 心脏病学
- 毒理学
- 关节病学
背景情况:
- 伴随心力衰竭的未分化左心室缩 (LVH) 存在诊断上的挑战.
- 遗传和获得的LVH原因需要仔细考虑.
- 长期使用氧化 (HCQ) 引起的心肌病 (HCQ-CM) 是一种罕见但显著的并发症.
研究的目的:
- 报告一个HCQ-CM病例,表现为不明原因的LVH和心力衰竭.
- 强调在差异诊断中考虑HCQ-CM的重要性.
- 突出HCQ-CM的诊断和管理策略.
主要方法:
- 一个56岁的女性患有全身性红斑狼和渐进性心力衰竭.
- 心声检查显示LVH具有限制性生理学.
- 内心肌活检 (EMB) 证实HCQ-CM具有特征性的曲线性内置体.
主要成果:
- 患者出现呼吸障碍,疲劳和体液过量.
- 初步调查显示,这是一种透性心肌病.
- 停用HCQ导致显著的临床改善,在6个月后获得NYHA I类状态.
结论:
- 在长期接受HCQ治疗的患者中,应考虑使用HCQ- CM治疗,这些患者心力衰竭和LVH是无法解释的.
- 包括EMB在内的多参数诊断方法对于识别可逆原因至关重要.
- 及时诊断和治疗调整,如停止HCQ,可以导致显著的临床改善.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Rheumatic Heart Disease I: Introduction
38
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
38
Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Myocarditis I: Introduction
28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
Cardiomyopathy IV: Restrictive Cardiomyopathy
25
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
25


